Table S2 from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with SorafenibDaniel J. Crona,Andrew D. Skol,Veli-Matti Leppänen,Dylan M. Glubb,Amy S. Etheridge,Eleanor Hilliard,Carol E. Peña,Yuri K. Peterson,Nancy Klauber-DeMore,Kari K. Alitalo,Federico Innocenticrossref（2023）引用 0|浏览2关键词Renal Cell CarcinomaAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
